New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells

Despite relevant progress obtained by multimodal treatment, glioblastoma (GBM), the most aggressive primary brain tumor, is still incurable. The most encouraging advancement of GBM drug research derives from the identification of cancer stem cells (CSCs), since these cells appear to represent the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Würth, Roberto, Barbieri, Federica, Florio, Tullio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909978/
https://www.ncbi.nlm.nih.gov/pubmed/24527434
http://dx.doi.org/10.1155/2014/126586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909978/
https://www.ncbi.nlm.nih.gov/pubmed/24527434
http://dx.doi.org/10.1155/2014/126586

Ejemplares similares